These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 22354715)

  • 1. Comments on recent developments in stuttering treatment maintenance research using the Camperdown Program.
    Ingham RJ
    J Speech Lang Hear Res; 2012 Feb; 55(1):306-9; author reply 310-2. PubMed ID: 22354715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Webcam delivery of the Camperdown Program for adolescents who stutter: a phase I trial.
    Carey B; O'Brian S; Onslow M; Packman A; Menzies R
    Lang Speech Hear Serv Sch; 2012 Jul; 43(3):370-80. PubMed ID: 22232423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing treatment for adolescents who stutter: a phase I trial of the Camperdown Program.
    Hearne A; Packman A; Onslow M; O'Brian S
    Lang Speech Hear Serv Sch; 2008 Oct; 39(4):487-97. PubMed ID: 18820090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Telehealth delivery of the Camperdown Program for adults who stutter: a phase I trial.
    O'Brian S; Packman A; Onslow M
    J Speech Lang Hear Res; 2008 Feb; 51(1):184-95. PubMed ID: 18230865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reviewing the literature: comments on "The Camperdown Program: outcomes of a new prolonged-speech treatment model" (2003) for stuttering.
    Prins D; Ingham RJ
    J Speech Lang Hear Res; 2005 Oct; 48(5):1025-8; author reply 1029-32. PubMed ID: 16411792
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized controlled non-inferiority trial of a telehealth treatment for chronic stuttering: the Camperdown Program.
    Carey B; O'Brian S; Onslow M; Block S; Jones M; Packman A
    Int J Lang Commun Disord; 2010; 45(1):108-20. PubMed ID: 19424889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary on Onslow, O'Brian and Harrison.
    Hayhow R
    Eur J Disord Commun; 1997; 32(2):258-66; discussion 261-6. PubMed ID: 9279421
    [No Abstract]   [Full Text] [Related]  

  • 8. A phase II clinical trial of self-imposed time-out treatment for stuttering in adults and adolescents.
    Hewat S; Onslow M; Packman A; O'Brian S
    Disabil Rehabil; 2006 Jan; 28(1):33-42. PubMed ID: 16393831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intensive stuttering modification therapy: a multidimensional assessment of treatment outcomes.
    Blomgren M; Roy N; Callister T; Merrill RM
    J Speech Lang Hear Res; 2005 Jun; 48(3):509-23. PubMed ID: 16197269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construct validity of modified time-interval analysis in measuring stuttering and trained speaking patterns.
    Alpermann A; Huber W; Natke U; Willmes K
    J Fluency Disord; 2012 Mar; 37(1):42-53. PubMed ID: 22325921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety Behaviors and Stuttering.
    Lowe R; Helgadottir F; Menzies R; Heard R; O'Brian S; Packman A; Onslow M
    J Speech Lang Hear Res; 2017 May; 60(5):1246-1253. PubMed ID: 28525541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating functional measures with treatment: a tactic for enhancing personally significant change in the treatment of adults and adolescents who stutter.
    Ingham RJ; Ingham JC; Bothe AK
    Am J Speech Lang Pathol; 2012 Aug; 21(3):264-77. PubMed ID: 22493023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Camperdown Program: outcomes of a new prolonged-speech treatment model.
    O'Brian S; Onslow M; Cream A; Packman A
    J Speech Lang Hear Res; 2003 Aug; 46(4):933-46. PubMed ID: 12959471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The long term effectiveness of intensive stuttering therapy: a mixed methods study.
    Irani F; Gabel R; Daniels D; Hughes S
    J Fluency Disord; 2012 Sep; 37(3):164-78. PubMed ID: 22682318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stuttering treatment for adults: an update on contemporary approaches.
    Blomgren M
    Semin Speech Lang; 2010 Nov; 31(4):272-82. PubMed ID: 21080299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Webcam delivery of the Camperdown Program for adolescents who stutter: a phase II trial.
    Carey B; O'Brian S; Lowe R; Onslow M
    Lang Speech Hear Serv Sch; 2014 Oct; 45(4):314-24. PubMed ID: 25091362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to "Intensive stuttering modification therapy: a multidimensional assessment of treatment outcomes," by Blomgren, Roy, Callister, and Merrill (2005).
    Reitzes P; Snyder G
    J Speech Lang Hear Res; 2006 Dec; 49(6):1420-2; author reply 1423-6. PubMed ID: 17197507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speech modification approaches to stuttering treatment in schools.
    Bothe AK
    Semin Speech Lang; 2002 Aug; 23(3):181-6. PubMed ID: 12207274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Follow-up of 6-10-year-old stuttering children after Lidcombe program treatment: a phase I trial.
    Koushik S; Shenker R; Onslow M
    J Fluency Disord; 2009 Dec; 34(4):279-90. PubMed ID: 20113771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Camperdown Program for adults who stutter: a student training clinic Phase I trial.
    Cocomazzo N; Block S; Carey B; O'Brian S; Onslow M; Packman A; Iverach L
    Int J Lang Commun Disord; 2012; 47(4):365-72. PubMed ID: 22788223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.